Related Experiment Video
Updated: May 16, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1
Bruce E Strober1, Jennifer Clay Cather, David Cohen
1Department of Dermatology, University of Connecticut School of Medicine, Farmington, CT 06032 USA.
Introduction:
Traditional clinical trials in psoriasis exclude a significant proportion of patients with complex disease and comorbidities. A consensus panel of 14 experts in the field of psoriasis was formed to conduct a Delphi method exercise to identify difficult-to-treat psoriasis clinical scenarios and to rank treatment approaches.
Methods:
The exercise consisted of both survey questionnaires and a live meeting to review and discuss current data (as of 2009, when the exercise was conducted) and arrive at a consensus for optimal treatment options. Seventy difficult treatment scenarios were identified, and the top 24 were selected for discussion at the live meeting.
Results:
Six of the 24 discussed case scenarios are presented in this article (another five are presented in Part 2): (1) psoriasis with human papilloma virus-induced cervical or anogenital dysplasia; (2) concomitant psoriasis and systemic lupus erythematosus; (3) severe psoriatic nail disease causing functional or emotional impairment; (4) psoriasis therapies that potentially reduce cardiovascular morbidity and mortality; (5) older patients (≥65 years of age) with psoriasis; and (6) severe scalp psoriasis that is unresponsive to topical therapy.
Conclusion:
The Delphi exercise resulted in guidelines for practicing physicians to utilize when confronted with challenging patients with psoriasis.
More Related Videos
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Peripheral Artery Disease III: Interprofessional Care
Ethical Dilemmas II
Psychosis: Goals of Pharmacotherapy
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Chronic Pancreatitis II: Collaborative Care
Assessment:
